Rigel Pharmaceuticals shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Rigel Pharmaceuticals (RIGL) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Rigel Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Rigel Pharmaceuticals held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Rigel Pharmaceuticals by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $15k | 536 | 27.04 |
| 2025-12-31 | $7.9k | 185 | 42.83 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas